...Travis Steed Travis Steed again, Bank of America medical device analyst. And next up, we are glad to have Penumbra, Adam Elsesser, President and CEO. So thanks for coming. Adam Elsesser Yeah, my pleasure. Thank you for having us. Travis Steed I wanted to start kind of like a big-picture question. You're one of the few companies to kind of go new IPO at a $1 billion market cap to now like $11 billion, $12 billion market cap. You don't see that very often. And I think you kind of reinvented your growth drivers. You're in competitive markets, like maybe we think they're more competitive than they really are, but they're pretty competitive markets. So like what's kind of been your success for Penumbra over the past decade to take a company from $1 billion to $11 billion, $12 billion market cap?...